The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

In industry parlance, the deal joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build ...

Chroma Medicine and Nvelop Therapeutics have merged to form nChroma Bio and rounded up a $75 million financing.

Two Boston-area biotechs are shedding staff and merging together to form a new genetic medicines company. | Chroma Medicines ...

The new company has also raised $75 million that will support the development of epigenetic editing therapies for hepatitis B ...

Chroma, a startup building a new type of audiovisual entertainment for mobile devices, has been sold. The company, which had financial backing from Twitter and Medium co-founder Biz Stone as well ...

The merger of Nvelop Therapeutics and Chroma Medicine brings together a combination of epigenetic editing and in vivo ...

Chroma Ate designs and manufactures precision ... and electric vehicles industries. Founded in 1984, the company is headquartered in Taoyuan, Taiwan.

Chroma, a startup building a new type of audiovisual entertainment for mobile devices, has been sold. The company, which had financial backing from Twitter and Medium co-founder Biz Stone as well ...